Product Catalog

Research Topics

Your Position: Home
> Acute Lymphoblastic Leukemia Therapeutic Targets Acute Lymphoblastic Leukemia Therapeutic Targets
| Protein Name | Alternative Names | BioChemical Class / Role | Products (Cat NO)![]() |
||
| Protein | Antibody | Gene cDNA clones | |||
| FLT-3/CD135/FLK-2 | RP11-153M24.3, STK1 | FL cytokine receptor, also known as tyrosine-protein kinase receptor FLT3, Stem cell tyrosine kinase 1, STK-1, FLT3 and CD135, is a single-pass type I membrane protein. Signaling through CD135 plays a role in cell survival, proliferation, and differentiation. CD135 is also important for lymphocyte (B cell and T cell) development, but not for the development of other blood cells (myeloid development). Identified as a proto-oncogene, the mutations of FLTS gene are associated with certain carcinomas. | 10445-H08H | HG10445-M | |
| CDK2 | p33(CDK2) | CDK2 (cyclin-dependent kinase 2), is a member of the cyclin-dependent kinase family(CDK)of Ser/Thr protein kinases. Some researchers demonstrated an unpredicted participation of CDK2 in the accurate pairing and recombination between homologues during mammalian meiosis. CDK2 was thought to be a crucial regulator of S-phase progression and was evaluated as an anticancer drug target. | 10624-H08B | HG10624-M | |

+86-400-890-9989


